Skip to main content
NAMS $21.49 -0.05%
NAMS logo
NAMS · NewAmsterdam Pharma Co N.V.
Track NAMS — free
$21.49 -0.01 (-0.05%) At close · Oct 21
Market Cap
$2.57B
Shares
119.54M
Volume · Oct 21 1.25M Avg daily vol (3M) 1.39M
All webcasts

Earnings call · FY2025 Q4

NewAmsterdam Pharma Co N.V. (NAMS) Q4 2025 Earnings Call

Concluded Feb 11, 2026
Feb 11, 2026 0 turns
Period
FY2025 Q4
Runtime
—
Sources
3 artifacts
Revenue · derived Q4 $32,000 -99.7% YoY
Net income · derived Q4 -$74.92M
Open full screen Slides 6 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document